Polyherbal formulation having more than one plant in the particular dosage form. These formulation shows greater therapeutic efficacy compared to single plant. In the present study. It was intended to formulate antidiabetic polyherbal formulation incorporating different ratio of the Annona squamosa (leaves), Withania somnifera (roots), Tinospora cordifolia (stems)and Azadirachta indica (leaves). The seven different polyherbal formulation (HF1 to HF7) were prepared and administered orally to the streptozotocin induced diabetic rats. The experimental rats treated with the HF1 to HF7 and reference drug Glibenclamide significantly reduced the blood glucose level compared to the diabetic control group. Further, the HF1 to HF7 showed antihyperlipidemic activity by lowering the total cholesterol, triglycerides and low-density lipoprotein level as well asenhanced the high-density lipoprotein. The polyherbal formulations and reference drug improve the body wights of the rats. The HF6 demonstrated greater antidiabetic and antihyperlipidemic activity compared to other polyherbal formulations.

The commodity derivative market in India has gained an important place in the last few decades. However, the entry of ‘tea futures’ in the derivative market is yet to come. Tea is a substitute for coffee and has a good market worldwide. India’s contribution to world production of tea is significant, but the presence of tea futures in Indian derivative market is yet to be seen whereas coffee, being a similar commodity, has a good place in the derivatives market. This study makes an attempt to examine the feasibility of tea futures in India by studying two leading conditions for tea in comparison with coffee. The study examines the market conditions by studying the export potentiality that signifies the demand and supply; and price volatility of tea price. The observations and analysis find favourable grounds for the introduction of tea futures in the commodity derivative market to extend the benefits to various groups like tea growers and manufacturers.

It was intended to developed and evaluate polyherbal tablet consisting dry powder of aqueous extract of Tinospora cordifolia,Annona squamosa,Withaniasomnifera,and Azadirachta indica.The aqueous extract of Tinospora cordifolia,Annona squamosa,Withaniasomnifera,and Azadirachta indicawere formulated. The direct compression approach was used to create all six distinct pills (HF1 to HF6) in the batch. The mixtures were tested for their flow qualities and their compressibility, and the results showed that they were successful in both categories. A single rotatory punching machine was utilised throughout the production of the tablets. After that, the compressed tablets were put through a variety of different physical tests, including evaluations of their diameter, thickness, weight variability, variation in hardness, friability, in vitro disintegration time, and in vitro dissolution. The outcomes of each of these tests came back as positive, which is a good sign.